GVR Report cover Alopecia Market Size, Share & Trends Report

Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment, By Gender, By Sales Channel, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-856-5
  • Number of Report Pages: 120
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Alopecia Market Size & Trends

The global alopecia market size was valued at USD 8.77 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2030. One of the major driving factors for the market is the increasing awareness regarding alopecia treatment options, as people are becoming more conscious of their appearance and actively seeking solutions to address hair loss.

North America Alopecia Market size and growth rate, 2024 - 2030

Increasing prevalence of hair loss, technological advancements in alopecia treatment, and the rise in prevalence of chronic diseases that are associated with hair loss are some of the major factors driving the market growth globally. According to data published by the American Hair Loss Association, it was stated that over 95% of hair loss in men is caused due to androgenetic alopecia. Similarly, data published by the International Society of Hair Restoration Surgery, it was estimated that nearly 40% of men encounter some degree of hair loss by 35 years of age, 65% at 60 years, 70% at 80 years, and 80% at the age of 85.Owing to these factors, the androgenetic alopecia market size in terms of revenue is estimated to grow at a significant growth rate during the forecast period.

The growing prevalence of hair loss is one of the major factors driving the alopecia treatment market. According to data published by the Journal of Clinical and Diagnostic Research (JCDR), around 60% of the global population has hair thinning problems and pattern hair loss is the most common form of hair loss in both males and females. Moreover, around 2% of the global population is at risk of developing alopecia areata in their lifetime globally, irrespective of gender.

The global rise in healthcare expenditure is also a major factor in the market's growth. Major countries in North America, Asia Pacific, Latin America, and Europe are witnessing a significant increase in per capita healthcare expenditure. For instance, according to the American Medical Association article published in March 2023, the healthcare expenditure in the U.S. increase by 2.7% in 2021 than previous year to USD 12,914 per capita or USD 4.3 trillion. Moreover, according to the Office for National Statistics (ONS) article published in May 2023, the UK's healthcare expenditure in 2022 was approximately USD 304.55 billion, an increase of 0.7% over the previous year.

Key factors responsible for the increase in healthcare expenditure include increasing consumer disposable income and growing emphasis on aesthetic appearance. Furthermore, according to the OECD data, healthcare expenditure is increasing in developed as well as developing countries, which may help bridge the infrastructure gap in addressing the unmet medical needs of the population.

An increase in the number of initiatives being undertaken by organizations, such as the National Alopecia Areata Foundation and the American Hair Loss Association, for spreading awareness about hair regrowth and available treatment options are leading to an increase in healthcare expenditure. The Affordable Care Act of 2010 provides people with affordable access to healthcare insurance, thus providing benefits to economically weaker patients. This results in an overall increase in the treatment rate, which is expected to fuel the growth of the market. Furthermore, increasing awareness regarding hair loss is increasing the demand for pain-less therapy with minimal side effects is fueling the treatment rate globally.

Market Concentration & Characteristics

The market growth stage is high, and pace of the market growth is accelerating. The alopecia market is characterized by a high degree of innovation.The alopecia market has witnessed significant innovation in recent years across various domains. Advances include new formulations in topical and oral therapies, exploration of biotechnological approaches like Low-Level Laser Therapy (LLLT), stem cell research, precision medicine for personalized treatments, and advancements in hair transplant techniques. In addition, low-level laser therapy, nutraceuticals, supplements, and digital health solutions contribute to diverse options for individuals dealing with hair loss.

The alopecia market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to gain access to technologies and formulations, the need to consolidate in a rapidly growing market, and increasing need for solution.

Alopecia Market Concentration & Characteristics

The alopecia market is subjected to regulatory scrutiny. Regulations in the alopecia market have a profound impact on product development, safety, and market entry. Clinical trial and approval processes, enforced by regulatory authorities like the FDA and the European Medicines Agency (EMA), ensure the stringent evaluation of treatments before entering the market. Quality and safety standards mandated by regulations are crucial, ensuring that the treatment meet specified criteria for efficacy and safety. Additionally, regulations govern labeling and marketing, preventing misleading claims and safeguarding consumer information.

There are a several number of product substitutes in the alopecia market. Individuals have various product substitutes and alternative approaches to address hair loss. These include topical products like minoxidil, oral medications such as finasteride, hair growth shampoos, and nutritional supplements. Non-pharmaceutical options include low-level laser therapy devices, platelet-rich plasma (PRP) therapy, cosmetic solutions, and hair extensions/wigs.

End-user concentration is a significant factor in the alopecia market. The increase in end users in the alopecia market is driven by increasing awareness of hair loss conditions, changing beauty standards, advancements in treatment options, increased stress and lifestyle factors, easy access to information, and more. This collective influence encourages individuals to seek professional advice and explore various products and services to address their hair loss concerns.

Disease Type Insights

Alopecia areata held the largest market share of 34.61% in 2023, driven by high disease prevalence and growing consumer awareness among patients. According to National Alopecia Areata Foundation, around 147 million people are affected by alopecia areata globally, out of this, around 6.8 million people live in the U.S. only. Alopecia areata market size in terms of revenue is anticipated to grow at a significant growth rate over the forecast period owing to the rise in the development of novel therapy and favorable initiatives in the approval process. For instance, in October 2023, Sun Pharmaceutical Industries Ltd announced the acceptance of a New Drug Application (NDA) by the U.S. FDA. The NDA will be used for deuruxolitinib to treat severe alopecia areata.

The alopecia universalis segment is anticipated to grow at the fastest CAGR over the forecast period. Increasing awareness regarding severe forms of hair loss and an increase in research activities to develop novel and effective treatment options is expected to drive the market growth over the forecast period. According to the Genetic and Rare Diseases Information Center (GARD), around 7% to 25% of people suffering from alopecia areata develop alopecia totalis and universalis. Moreover, the presence of pipeline drugs such as baricitinib, deuruxolitinib, and ritlecitinib for the treatment of severe conditions of alopecia areata is expected to propel the segment growth over the forecast period.

Treatment Type Insights

The pharmaceutical segment dominates the global alopecia market. This dominance is primarily attributed to the affordability of pharmaceutical products and high usage of prescription and OTC drugs. Finasteride and minoxidil are the most common drugs used to treat any form of hair loss. Finasteride and minoxidil are the only U.S. approved drugs for the treatment of both Female Pattern Hair Loss (FPHL) and as well as Male Pattern Hair Loss (MPHL). Moreover, the major pharmaceutical companies such as Lilly, Pfizer Inc., Concert Pharmaceuticals are actively involved in the development of novel drugs to treat alopecia, which is anticipated to drive the market growth over the forecast period. For instance, in December 2023, Aclaris Therapeutics announced a license agreement with Sun Pharmaceutical Industries, Inc. This agreement will enable Aclaris Therapeutics to access Sun Pharma's JAK inhibitor and other isotopic forms of ruxolitinib to treat androgenetic or alopecia areata.

The devices segment is expected to grow at the fastest growth rate during the forecast period. Increasing adoption of painless treatment coupled with minimal side effects and adoption of home-used laser devices are forces driving the segment growth in the next 5 to 8 years. Low-level laser therapy offers the convenience of at-home use and minimizes the need for clinical visits. Moreover, it provides a non-pharmacological and non-surgical viable therapeutic action for hair restoration due to which the market is expected to grow steadily over the forecast period. FDA clearance for low-level laser therapy devices, such as iRestore and Hairmax, for treatment of most commonly occurring forms of alopecia, such as the androgenetic alopecia, is likely to boost the market growth for the same over the forecast period.

Gender Insights

The male segment dominated the market in 2023, owing to the high prevalence of hair loss in the male population worldwide. Androgenetic alopecia is the most common hair loss type in the male population. It is estimated that approximately 50 percent of men experience some degree of hair loss at an average age of 50 with over 95% of cases being the androgenetic type. Moreover, factors such as the increased amount of tobacco intake in men and a rising geriatric population, are expected to further propel the market over the forecast period.

However, the female alopecia market is anticipated to grow at the fastest rate over the forecast period. The female segment is experiencing rapid growth in the alopecia market due to increased awareness, changing societal norms, stress and lifestyle factors, advancements in treatment options, social media influence, hormonal changes, targeted marketing, and an aging population. These factors collectively contribute to hair loss in women, driving the demand for alopecia treatments and encouraging the development of specialized solutions for the female demographic.

Sales Channel Insights

The sales channel for the alopecia market is dominated by the prescription segment with the highest share due to the high number of visits to dermatologists for hair loss treatment. According to the National Library of Medicine, around 2.6 million outpatients visit dermatologists for alopecia areata treatment in the U.S. annually. Moreover, a strong product pipeline, growing disposable incomes, and rising prevalence of chronic diseases which ultimately leads to hair loss are expected to drive the segment growth at the fastest rate over the forecast period.

However, the OTC segment is driving the market with a significant growth rate. It is widely used in the developing regions where players find multiple opportunities to address unmet medical needs of a large patient pool across countries such as China, Japan, Mexico, Brazil, and India. Moreover, OTC drugs remain the preferred choice of medication amongst males suffering from androgenetic alopecia and for other types of hair loss conditions where there is a lack of approved drugs, leading consumers to rely on off-label or OTC drugs. The alopecia areata treatment cost is generally affordable in the OTC segment, hence it gathers higher adoption rate, especially in the emerging countries.

End-use Insights

The end-use market for alopecia is currently dominated by dermatology clinics with the highest share and is also expected to grow strongly over the forecast period. Modern treatment methods such as laser technology, a strong product pipeline, and heightened consumer awareness regarding the use of prescription medicines are the main factors responsible for the continued growth of the segment. Given the consulting dermatologist’s ability to provide appropriate customized medications or therapy that yield effective results, they are often considered the preferred option for the treatment of alopecia.

Global Alopecia Market share and size, 2023

The home care setting segment will be the fastest-growing segment over the forecast period owing to convenience, ease of usage, and patient comfort. Moreover, there are a growing number of regulatory approvals being given for home-use devices in addition to the growing adoption of non-invasive procedures such as laser therapy that do not require any lifestyle changes. For instance, in June 2023, the FDA approved the alopecia areata treatment by Yale. The treatment uses ritlecitinib - a Janus kinase (JAK) inhibitor that can be used to treat alopecia areata for adolescents and adults.

Regional Insights

North America commanded the regional shares in alopecia treatment in 2023 with a share of 38.34%, driven by a high prevalence of the disease, increased awareness among consumers, proactive measures taken by the government, improvements in healthcare infrastructure, and advancements in technology. In addition, rising adoption of laser-based therapy for treatment has contributed to an increase in the treatment rate in North America. Moreover, the presence of government and non-profit organizations such as the National Alopecia Areata Foundation (NAAF), Canadian Alopecia Areata Foundation, and others provide guidelines and create awareness among people, is likely to have a positive impact on the market.

The Asia Pacific region is estimated to grow at the fastest CAGR for the forecast period. There has been an increase in the prevalence of alopecia in several Asian countries, driving the demand for effective treatment options. Rising awareness about hair loss and its impact on quality of life has also contributed to the market's growth. Additionally, the increasing disposable income and changing lifestyles of the population have led to a higher willingness to spend on hair loss treatments. Moreover, increasing clinical trials in countries like China, India, and Japan are boosting the regional market. For instance, in August 2023, Kintor Pharmaceutical Limited announced the completion of the enrollment process for the phase II clinical trial for treating male androgenetic alopecia in China.

Key Companies & Market Share Insights

Some of the key players operating in the market include AbbVie, Inc., Bayer AG, Merck & Co., Inc., Curallux, LLC (Capillus), Lexington Intl., LLC. (HairMax), LUTRONIC, and Pfizer, Inc. Key players are introducing novel products in the market to strengthen their portfolios.The launch of new products may help the company strengthen its position in the market. Additionally, partnership with local players and service providers is expected to increase the adoption of innovative therapy for alopecia treatment.

Apira Science Inc. (iGROW Laser), LG Electronics, Inc., REVIAN, Inc., WON TECH Co., Ltd., HairPro Laser, Dr Cure and Care, Modern Aesthetics, CNV Hair, NutraStim are some of the emerging market participants. These players are adopting various strategic initiatives, such as product launches, mergers & acquisitions, and partnerships, to maintain their position in the market.

Key Alopecia Companies:

  • Janssen Global Services Inc.
  • Cipla Limited
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Sun Pharmaceuticals Industries Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Aurobindo Pharma
  • Viatris Inc.
  • Pfizer, Inc.
  • Lilly
  • Lexington Intl., LLC (Devices)
  • Freedom Laser Therapy (iRestore ID-520 helmet)
  • Curallux, LLC.
  • Apira Science Inc. (iGROW Laser)
  • Revian Inc.
  • Theradome
  • Lutronic

Recent Developments

  • In July 2023, REVIAN Inc. announced that the Revian Red Hair Growth System is expected to be in a second study. It is anticipated as an effective treatment option for Central Centrifugal Cicatricial Alopecia ("CCCA").

  • In June 2023, Pfizer Inc. announced the approval of LITFULO by the U.S. FDA. It is the first treatment that is approved and used for adolescents (12+) to treat severe alopecia areata.

  • In January 2023, Sun Pharmaceuticals Industries Ltd announced the acquisition of Concert Pharmaceuticals. The latter is a biotechnology company specializing in treating alopecia areata.

Alopecia Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 9.48 billion

Revenue forecast in 2030

USD 16.02 billion

Growth rate

CAGR of 9.1% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Disease type, treatment, gender, sales channel, ed-use, region

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S., Canada, Germany, U.K., France, Italy, Spain, Denmark, Norway, Sweden, China, Japan, India, South Korea, Australia, Thailand, Brazil, Mexico, Argentina, UAE, South Africa, Saudi Arabia, Kuwait

Key companies profiled

Janssen Global Services Inc.; Cipla Limited; Merck & Co., Inc.; GlaxoSmithKline plc; Sun Pharmaceuticals Industries Ltd; Dr. Reddy’s Laboratories Ltd; Aurobindo Pharma; Viatris Inc.; Pfizer, Inc.; Lilly; Lexington Intl., LLC (Devices); Freedom Laser Therapy (iRestore ID-520 helmet); Curallux, LLC.; Apira Science Inc. (iGROW Laser); Revian Inc.; Theradome; Lutronic

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Alopecia Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global alopecia market report based on disease type, treatment, gender, sales channel, end-use, and region:

  • Disease Type Outlook (Revenue, USD Million; 2018 - 2030)

    • Alopecia Areata

      • Male

      • Female

    • Cicatricial Alopecia

      • Male

      • Female

    • Traction Alopecia

      • Male

      • Female

    • Alopecia Totalis

      • Male

      • Female

    • Alopecia Universalis

      • Male

      • Female

    • Androgenetic Alopecia

      • Male

      • Female

    • Others

      • Male

      • Female

  • Treatment Outlook (Revenue, USD Billion, 2018 - 2030)

    • Pharmaceuticals

      • Topical

        • OTC

          • Minoxidil

          • Others

        • Prescription

          • Betamethasone Dipropionate

          • Fluocinolone Acetonide

          • Finasteride

          • Minoxidil

      • Oral

        • OTC

          • Prescription

          • Minoxidil

          • Finasteride

          • Corticosteroids

          • Others (JAK inhibitors and others)

      • PRP 

    • Devices

      • Laser Cap

      • Laser Comb

      • Laser Helmet

  • Gender Outlook (Revenue, USD Billion, 2018 - 2030)

    • Male

    • Female

  • Sales Channel Outlook (Revenue, USD Billion, 2018 - 2030)

    • Prescriptions

    • OTC

  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)

    • Homecare Settings

    • Dermatology Clinics

  • Regional Outlook (Revenue, USD Billion, 2018 - 2030) 

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Spain

      • Italy

      • Denmark

      • Norway

      • Sweden

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • UAE

      • Saudi Arabia

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Disease Type
                        1.2.2. Treatment
                        1.2.3. Gender
                        1.2.4. Sales Channel
                        1.2.5. End Use
                        1.2.6. Regional scope
                        1.2.7. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Disease Type
                        2.2.2. Treatment
                        2.2.3. Gender
                        2.2.4. Sales Channel
                        2.2.5. End Use
                        2.2.6. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Alopecia Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing global prevalence of alopecia
                            3.2.1.2. Increasing global healthcare expenditure
                            3.2.1.3. Increasing prevalence of chronic diseases
                                3.2.1.3.1. PCOS
                                3.2.1.3.2. Cancer
                                3.2.1.3.3. Rheumatoid Arthritis
                            3.2.1.4. Technological advancements in alopecia treatment
                        3.2.2. Market restraint analysis
                            3.2.2.1. Lack of reimbursement policies for alopecia treatment
                            3.2.2.2. Increasing adoption of substitutes
                    3.3. Alopecia Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                    3.4. Pricing Analysis
Chapter 4. Alopecia Market: Disease Type Estimates & Trend Analysis
                    4.1. Disease Type Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Alopecia Market by Disease Type Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Alopecia Areata
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.1.2. Male
                                4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.1.3. Female
                                4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Cicatricial Alopecia
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.2. Male
                                4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.3. Female
                                4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Traction Alopecia
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.2. Male
                                4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.3. Female
                                4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Alopecia Totalis
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.4.2. Male
                                4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.4.3. Female
                                4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.5. Alopecia Universalis
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.5.2. Male
                                4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.5.3. Female
                                4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.6. Androgenetic Alopecia
                            4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.6.2. Male
                                4.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.6.3. Female
                                4.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.7. Others
                            4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.7.2. Male
                                4.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.7.3. Female
                                4.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Alopecia Market: Treatment Estimates & Trend Analysis
                    5.1. Treatment Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Alopecia Market by Treatment Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. Pharmaceuticals
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            5.4.1.2. Topical
                                5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                5.4.1.2.2. OTC
                                    5.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.2.2.2. Minoxidil
                                        5.4.1.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.2.2.3. Others
                                        5.4.1.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                5.4.1.2.3. Prescription
                                    5.4.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.2.3.2. Betamethasone Dipropionate
                                        5.4.1.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.2.3.3. Fluocinolone Acetonide
                                        5.4.1.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.2.3.4. Finasteride
                                        5.4.1.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.2.3.5. Minoxidil
                                        5.4.1.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            5.4.1.3. Oral
                                5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                5.4.1.3.2. OTC
                                    5.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                5.4.1.3.3. Prescription
                                    5.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.3.3.2. Minoxidil
                                        5.4.1.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.3.3.3. Finasteride
                                        5.4.1.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.3.3.4. Corticosteroids
                                        5.4.1.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                    5.4.1.3.3.5. Others (JAK inhibitors and others)
                                        5.4.1.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            5.4.1.4. PRP
                                5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.2. Devices
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            5.4.2.2. Laser Cap
                                5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                                5.4.2.2.2. Laser Comb
                                5.4.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
                                5.4.2.2.4. Laser Helmet
                                5.4.2.2.5. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Alopecia Market: Gender Estimates & Trend Analysis
                    6.1. Gender Market Share, 2023 & 2030
                    6.2. Segment Dashboard
                    6.3. Global Alopecia Market by Gender Outlook
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        6.4.1. Prescriptions
                            6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        6.4.2. Female
                            6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Alopecia Market: Sales Channel Estimates & Trend Analysis
                    7.1. Sales Channel Market Share, 2023 & 2030
                    7.2. Segment Dashboard
                    7.3. Global Alopecia Market by Gender Outlook
                    7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        7.4.1. Prescription
                            7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        7.4.2. OTC
                            7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Alopecia Market: End Use Estimates & Trend Analysis
                    8.1. End Use Market Share, 2023 & 2030
                    8.2. Segment Dashboard
                    8.3. Global Alopecia Market by End Use Outlook
                    8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        8.4.1. Homecare Settings
                            8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        8.4.2. Dermatology Clinics
                            8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Alopecia Market: Regional Estimates & Trend Analysis
                    9.1. Regional Market Share Analysis, 2023 & 2030
                    9.2. Regional Market Dashboard
                    9.3. Global Regional Market Snapshot
                    9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    9.5. North America
                        9.5.1. U.S.
                            9.5.1.1. Key country dynamics
                            9.5.1.2. Regulatory framework/ reimbursement structure
                            9.5.1.3. Competitive scenario
                            9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        9.5.2. Canada
                            9.5.2.1. Key country dynamics
                            9.5.2.2. Regulatory framework/ reimbursement structure
                            9.5.2.3. Competitive scenario
                            9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                    9.6. Europe
                        9.6.1. UK
                            9.6.1.1. Key country dynamics
                            9.6.1.2. Regulatory framework/ reimbursement structure
                            9.6.1.3. Competitive scenario
                            9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        9.6.2. Germany
                            9.6.2.1. Key country dynamics
                            9.6.2.2. Regulatory framework/ reimbursement structure
                            9.6.2.3. Competitive scenario
                            9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        9.6.3. France
                            9.6.3.1. Key country dynamics
                            9.6.3.2. Regulatory framework/ reimbursement structure
                            9.6.3.3. Competitive scenario
                            9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        9.6.4. Italy
                            9.6.4.1. Key country dynamics
                            9.6.4.2. Regulatory framework/ reimbursement structure
                            9.6.4.3. Competitive scenario
                            9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        9.6.5. Spain
                            9.6.5.1. Key country dynamics
                            9.6.5.2. Regulatory framework/ reimbursement structure
                            9.6.5.3. Competitive scenario
                            9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        9.6.6. Norway
                            9.6.6.1. Key country dynamics
                            9.6.6.2. Regulatory framework/ reimbursement structure
                            9.6.6.3. Competitive scenario
                            9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        9.6.7. Sweden
                            9.6.7.1. Key country dynamics
                            9.6.7.2. Regulatory framework/ reimbursement structure
                            9.6.7.3. Competitive scenario
                            9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        9.6.8. Denmark
                            9.6.8.1. Key country dynamics
                            9.6.8.2. Regulatory framework/ reimbursement structure
                            9.6.8.3. Competitive scenario
                            9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    9.7. Asia Pacific
                        9.7.1. Japan
                            9.7.1.1. Key country dynamics
                            9.7.1.2. Regulatory framework/ reimbursement structure
                            9.7.1.3. Competitive scenario
                            9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        9.7.2. China
                            9.7.2.1. Key country dynamics
                            9.7.2.2. Regulatory framework/ reimbursement structure
                            9.7.2.3. Competitive scenario
                            9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        9.7.3. India
                            9.7.3.1. Key country dynamics
                            9.7.3.2. Regulatory framework/ reimbursement structure
                            9.7.3.3. Competitive scenario
                            9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        9.7.4. Australia
                            9.7.4.1. Key country dynamics
                            9.7.4.2. Regulatory framework/ reimbursement structure
                            9.7.4.3. Competitive scenario
                            9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        9.7.5. South Korea
                            9.7.5.1. Key country dynamics
                            9.7.5.2. Regulatory framework/ reimbursement structure
                            9.7.5.3. Competitive scenario
                            9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        9.7.6. Thailand
                            9.7.6.1. Key country dynamics
                            9.7.6.2. Regulatory framework/ reimbursement structure
                            9.7.6.3. Competitive scenario
                            9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    9.8. Latin America
                        9.8.1. Brazil
                            9.8.1.1. Key country dynamics
                            9.8.1.2. Regulatory framework/ reimbursement structure
                            9.8.1.3. Competitive scenario
                            9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        9.8.2. Mexico
                            9.8.2.1. Key country dynamics
                            9.8.2.2. Regulatory framework/ reimbursement structure
                            9.8.2.3. Competitive scenario
                            9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                        9.8.3. Argentina
                            9.8.3.1. Key country dynamics
                            9.8.3.2. Regulatory framework/ reimbursement structure
                            9.8.3.3. Competitive scenario
                            9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    9.9. MEA
                        9.9.1. South Africa
                            9.9.1.1. Key country dynamics
                            9.9.1.2. Regulatory framework/ reimbursement structure
                            9.9.1.3. Competitive scenario
                            9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        9.9.2. Saudi Arabia
                            9.9.2.1. Key country dynamics
                            9.9.2.2. Regulatory framework/ reimbursement structure
                            9.9.2.3. Competitive scenario
                            9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        9.9.3. UAE
                            9.9.3.1. Key country dynamics
                            9.9.3.2. Regulatory framework/ reimbursement structure
                            9.9.3.3. Competitive scenario
                            9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        9.9.4. Kuwait
                            9.9.4.1. Key country dynamics
                            9.9.4.2. Regulatory framework/ reimbursement structure
                            9.9.4.3. Competitive scenario
                            9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Recent Developments & Impact Analysis, By Key Market Participants
                    10.2. Company/Competition Categorization
                    10.3. Vendor Landscape
                        10.3.1. List of key distributors and channel partners
                        10.3.2. Key customers
                        10.3.3. Key company market share analysis, 2023
                        10.3.4. Janssen Global Services Inc.
                            10.3.4.1. Company overview
                            10.3.4.2. Financial performance
                            10.3.4.3. Product benchmarking
                            10.3.4.4. Strategic initiatives
                        10.3.5. Cipla Limited
                            10.3.5.1. Company overview
                            10.3.5.2. Financial performance
                            10.3.5.3. Product benchmarking
                            10.3.5.4. Strategic initiatives
                        10.3.6. Merck & Co., Inc.
                            10.3.6.1. Company overview
                            10.3.6.2. Financial performance
                            10.3.6.3. Product benchmarking
                            10.3.6.4. Strategic initiatives
                        10.3.7. GlaxoSmithKline plc
                            10.3.7.1. Company overview
                            10.3.7.2. Financial performance
                            10.3.7.3. Product benchmarking
                            10.3.7.4. Strategic initiatives
                        10.3.8. Sun Pharmaceuticals Industries Ltd
                            10.3.8.1. Company overview
                            10.3.8.2. Financial performance
                            10.3.8.3. Product benchmarking
                            10.3.8.4. Strategic initiatives
                        10.3.9. Dr. Reddy’s Laboratories Ltd
                            10.3.9.1. Company overview
                            10.3.9.2. Financial performance
                            10.3.9.3. Product benchmarking
                            10.3.9.4. Strategic initiatives
                        10.3.10. Aurobindo Pharma
                            10.3.10.1. Company overview
                            10.3.10.2. Financial performance
                            10.3.10.3. Product benchmarking
                            10.3.10.4. Strategic initiatives
                        10.3.11. Viatris Inc.
                            10.3.11.1. Company overview
                            10.3.11.2. Financial performance
                            10.3.11.3. Product benchmarking
                            10.3.11.4. Strategic initiatives
                        10.3.12. Pfizer, Inc.
                            10.3.12.1. Company overview
                            10.3.12.2. Financial performance
                            10.3.12.3. Product benchmarking
                            10.3.12.4. Strategic initiatives
                        10.3.13. Lilly
                            10.3.13.1. Company overview
                            10.3.13.2. Financial performance
                            10.3.13.3. Product benchmarking
                            10.3.13.4. Strategic initiatives
                        10.3.14. Lexington Intl., LLC (Devices)
                            10.3.14.1. Company overview
                            10.3.14.2. Financial performance
                            10.3.14.3. Product benchmarking
                            10.3.14.4. Strategic initiatives
                        10.3.15. Freedom Laser Therapy (iRestore ID-520 helmet)
                            10.3.15.1. Company overview
                            10.3.15.2. Financial performance
                            10.3.15.3. Product benchmarking
                            10.3.15.4. Strategic initiatives
                        10.3.16. Curallux, LLC.
                            10.3.16.1. Company overview
                            10.3.16.2. Financial performance
                            10.3.16.3. Product benchmarking
                            10.3.16.4. Strategic initiatives
                        10.3.17. Apira Science Inc. (iGROW Laser)
                            10.3.17.1. Company overview
                            10.3.17.2. Financial performance
                            10.3.17.3. Product benchmarking
                            10.3.17.4. Strategic initiatives
                        10.3.18. Revian Inc.
                            10.3.18.1. Company overview
                            10.3.18.2. Financial performance
                            10.3.18.3. Product benchmarking
                            10.3.18.4. Strategic initiatives
                        10.3.19. Theradome
                            10.3.19.1. Company overview
                            10.3.19.2. Financial performance
                            10.3.19.3. Product benchmarking
                            10.3.19.4. Strategic initiatives
                        10.3.20. Lutronic
                            10.3.20.1. Company overview
                            10.3.20.2. Financial performance
                            10.3.20.3. Product benchmarking
                            10.3.20.4. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America alopecia market, by region, 2018 - 2030 (USD Million)
Table 3 North America alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 4 North America alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 5 North America alopecia market, by gender, 2018 - 2030 (USD Million)
Table 6 North America alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 7 North America alopecia market, by end user, 2018 - 2030 (USD Million)
Table 8 U.S. alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 9 U.S. alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 10 U.S. alopecia market, by gender, 2018 - 2030 (USD Million)
Table 11 U.S. alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 12 U.S. alopecia market, by end user, 2018 - 2030 (USD Million)
Table 13 Canada alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 14 Canada alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 15 Canada alopecia market, by gender, 2018 - 2030 (USD Million)
Table 16 Canada alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 17 Canada alopecia market, by end user, 2018 - 2030 (USD Million)
Table 18 Europe alopecia market, by region, 2018 - 2030 (USD Million)
Table 19 Europe alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 20 Europe alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 21 Europe alopecia market, by gender, 2018 - 2030 (USD Million)
Table 22 Europe alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 23 Europe alopecia market, by end user, 2018 - 2030 (USD Million)
Table 24 Germany alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 25 Germany alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 26 Germany alopecia market, by gender, 2018 - 2030 (USD Million)
Table 27 Germany alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 28 Germany alopecia market, by end user, 2018 - 2030 (USD Million)
Table 29 UK alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 30 UK alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 31 UK alopecia market, by gender, 2018 - 2030 (USD Million)
Table 32 UK alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 33 UK alopecia market, by end user, 2018 - 2030 (USD Million)
Table 34 France alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 35 France alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 36 France alopecia market, by gender, 2018 - 2030 (USD Million)
Table 37 France alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 38 France alopecia market, by end user, 2018 - 2030 (USD Million)
Table 39 Italy alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 40 Italy alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 41 Italy alopecia market, by gender, 2018 - 2030 (USD Million)
Table 42 Italy alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 43 Italy alopecia market, by end user, 2018 - 2030 (USD Million)
Table 44 Spain alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 45 Spain alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 46 Spain alopecia market, by gender, 2018 - 2030 (USD Million)
Table 47 Spain alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 48 Spain alopecia market, by end user, 2018 - 2030 (USD Million)
Table 49 Denmark alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 50 Denmark alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 51 Denmark alopecia market, by gender, 2018 - 2030 (USD Million)
Table 52 Denmark alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 53 Denmark alopecia market, by end user, 2018 - 2030 (USD Million)
Table 54 Sweden alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 55 Sweden alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 56 Sweden alopecia market, by gender, 2018 - 2030 (USD Million)
Table 57 Sweden alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 58 Sweden alopecia market, by end user, 2018 - 2030 (USD Million)
Table 59 Norway alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 60 Norway alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 61 Norway alopecia market, by gender, 2018 - 2030 (USD Million)
Table 62 Norway alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 63 Norway alopecia market, by end user, 2018 - 2030 (USD Million)
Table 64 Asia Pacific alopecia market, by region, 2018 - 2030 (USD Million)
Table 65 Asia Pacific alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 66 Asia Pacific alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 67 Asia Pacific alopecia market, by gender, 2018 - 2030 (USD Million)
Table 68 Asia Pacific alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 69 Asia Pacific alopecia market, by end user, 2018 - 2030 (USD Million)
Table 70 China alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 71 China alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 72 China alopecia market, by gender, 2018 - 2030 (USD Million)
Table 73 China alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 74 China alopecia market, by end user, 2018 - 2030 (USD Million)
Table 75 Japan alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 76 Japan alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 77 Japan alopecia market, by gender, 2018 - 2030 (USD Million)
Table 78 Japan alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 79 Japan alopecia market, by end user, 2018 - 2030 (USD Million)
Table 80 India alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 81 India alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 82 India alopecia market, by gender, 2018 - 2030 (USD Million)
Table 83 India alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 84 India alopecia market, by end user, 2018 - 2030 (USD Million)
Table 85 South Korea alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 86 South Korea alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 87 South Korea alopecia market, by gender, 2018 - 2030 (USD Million)
Table 88 South Korea alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 89 South Korea alopecia market, by end user, 2018 - 2030 (USD Million)
Table 90 Australia alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 91 Australia alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 92 Australia alopecia market, by gender, 2018 - 2030 (USD Million)
Table 93 Australia alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 94 Australia alopecia market, by end user, 2018 - 2030 (USD Million)
Table 95 Thailand alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 96 Thailand alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 97 Thailand alopecia market, by gender, 2018 - 2030 (USD Million)
Table 98 Thailand alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 99 Thailand alopecia market, by end user, 2018 - 2030 (USD Million)
Table 100 Latin America alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 101 Latin America alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 102 Latin America alopecia market, by gender, 2018 - 2030 (USD Million)
Table 103 Latin America alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 104 Latin America alopecia market, by end user, 2018 - 2030 (USD Million)
Table 105 Brazil alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 106 Brazil alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 107 Brazil alopecia market, by gender, 2018 - 2030 (USD Million)
Table 108 Brazil alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 109 Brazil alopecia market, by end user, 2018 - 2030 (USD Million)
Table 110 Mexico alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 111 Mexico alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 112 Mexico alopecia market, by gender, 2018 - 2030 (USD Million)
Table 113 Mexico alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 114 Mexico alopecia market, by end user, 2018 - 2030 (USD Million)
Table 115 Argentina alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 116 Argentina alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 117 Argentina alopecia market, by gender, 2018 - 2030 (USD Million)
Table 118 Argentina alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 119 Argentina alopecia market, by end user, 2018 - 2030 (USD Million)
Table 120 MEA alopecia market, by region, 2018 - 2030 (USD Million)
Table 121 MEA alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 122 MEA alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 123 MEA alopecia market, by gender, 2018 - 2030 (USD Million)
Table 124 MEA alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 125 MEA alopecia market, by end user, 2018 - 2030 (USD Million)
Table 126 South Africa alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 127 South Africa alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 128 South Africa alopecia market, by gender, 2018 - 2030 (USD Million)
Table 129 South Africa alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 130 South Africa alopecia market, by end user, 2018 - 2030 (USD Million)
Table 131 Saudi Arabia alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia alopecia market, by gender, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia alopecia market, by end user, 2018 - 2030 (USD Million)
Table 136 UAE alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 137 UAE alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 138 UAE alopecia market, by gender, 2018 - 2030 (USD Million)
Table 139 UAE alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 140 UAE alopecia market, by end user, 2018 - 2030 (USD Million)
Table 141 Kuwait alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 142 Kuwait alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 143 Kuwait alopecia market, by gender, 2018 - 2030 (USD Million)
Table 144 Kuwait alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 145 Kuwait alopecia market, by end user, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Alopecia market: market outlook
Fig. 14 Alopecia competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Alopecia market driver impact
Fig. 20 Alopecia market restraint impact
Fig. 21 Alopecia market strategic initiatives analysis
Fig. 22 Alopecia market: Disease type movement analysis
Fig. 23 Alopecia market: Disease type outlook and key takeaways
Fig. 24 Alopecia areata market estimates and forecast, 2018 - 2030
Fig. 25 Male alopecia areata market estimates and forecast, 2018 - 2030
Fig. 26 Female alopecia areata market estimates and forecast, 2018 - 2030
Fig. 27 Cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 28 Male cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 29 Female cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 30 Traction alopecia market estimates and forecast, 2018 - 2030
Fig. 31 Male traction market estimates and forecast, 2018 - 2030
Fig. 32 Female traction market estimates and forecast, 2018 - 2030
Fig. 33 Alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 34 Male alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 35 Female alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 36 Alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 37 Male alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 38 Female alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 39 Androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 40 Male androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 41 Female androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 42 Other alopecia market estimates and forecast, 2018 - 2030
Fig. 43 Male other alopecia market estimates and forecast, 2018 - 2030
Fig. 44 Female other alopecia market estimates and forecast, 2018 - 2030
Fig. 45 Alopecia Market: Treatment movement Analysis
Fig. 46 Alopecia market: Treatment outlook and key takeaways
Fig. 47 Pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 48 Topical market estimates and forecasts,2018 - 2030
Fig. 49 Topical OTC pharmaceuticals market estimates and forecasts,2018 - 2030
Fig. 50 Topical OTC minoxidil market estimates and forecasts,2018 - 2030
Fig. 51 Topical OTC others market estimates and forecasts,2018 - 2030
Fig. 52 Topical prescription pharmaceuticals market estimates and forecasts,2018 - 2030
Fig. 53 Topical prescription betamethasone dipropionate market estimates and forecasts,2018 - 2030
Fig. 54 Topical prescription fluocinolone acetonide market estimates and forecasts,2018 - 2030
Fig. 55 Topical prescription finasteride market estimates and forecasts,2018 - 2030
Fig. 56 Topical prescription minoxidil market estimates and forecasts,2018 - 2030
Fig. 57 Oral pharmaceuticals market estimates and forecasts,2018 - 2030
Fig. 58 Oral OTC pharmaceuticals market estimates and forecasts,2018 - 2030
Fig. 59 Oral prescription pharmaceuticals market estimates and forecasts,2018 - 2030
Fig. 60 Oral prescription minoxidil market estimates and forecasts,2018 - 2030
Fig. 61 Oral prescription finasteride market estimates and forecasts,2018 - 2030
Fig. 62 Oral prescription corticosteroids market estimates and forecasts,2018 - 2030
Fig. 63 Oral prescription others (JAK inhibitors and others) market estimates and forecasts,2018 - 2030
Fig. 64 PRP market estimates and forecasts,2018 - 2030
Fig. 65 Devices market estimates and forecasts,2018 - 2030
Fig. 66 Laser cap market estimates and forecasts,2018 - 2030
Fig. 67 Laser comb market estimates and forecasts,2018 - 2030
Fig. 68 Laser helmet market estimates and forecasts,2018 - 2030
Fig. 69 Alopecia market: Gender movement analysis
Fig. 70 Alopecia market: Gender outlook and key takeaways
Fig. 71 Male market estimates and forecasts, 2018 - 2030
Fig. 72 Female market estimates and forecasts,2018 - 2030
Fig. 73 Alopecia market: Sales channel movement analysis
Fig. 74 Alopecia market: Sales channel outlook and key takeaways
Fig. 75 Prescriptions market estimates and forecasts, 2018 - 2030
Fig. 76 OTC market estimates and forecasts,2018 - 2030
Fig. 77 Alopecia market: End use movement analysis
Fig. 78 Alopecia market: End use outlook and key takeaways
Fig. 79 Homecare settings market estimates and forecasts, 2018 - 2030
Fig. 80 Dermatology clinics market estimates and forecasts,2018 - 2030
Fig. 81 Global alopecia market: Regional movement analysis
Fig. 82 Global alopecia market: Regional outlook and key takeaways
Fig. 83 Global alopecia market share and leading players
Fig. 84 North America market share and leading players
Fig. 85 Europe market share and leading players
Fig. 86 Asia Pacific market share and leading players
Fig. 87 Latin America market share and leading players
Fig. 88 Middle East & Africa market share and leading players
Fig. 89 North America: SWOT
Fig. 90 Europe SWOT
Fig. 91 Asia Pacific SWOT
Fig. 92 Latin America SWOT
Fig. 93 MEA SWOT
Fig. 94 North America, by country
Fig. 95 North America
Fig. 96 North America market estimates and forecasts, 2018 - 2030
Fig. 97 U.S.
Fig. 98 U.S. market estimates and forecasts, 2018 - 2030
Fig. 99 Canada
Fig. 100 Canada market estimates and forecasts, 2018 - 2030
Fig. 101 Europe
Fig. 102 Europe market estimates and forecasts, 2018 - 2030
Fig. 103 UK
Fig. 104 UK market estimates and forecasts, 2018 - 2030
Fig. 105 Germany
Fig. 106 Germany market estimates and forecasts, 2018 - 2030
Fig. 107 France
Fig. 108 France market estimates and forecasts, 2018 - 2030
Fig. 109 Italy
Fig. 110 Italy market estimates and forecasts, 2018 - 2030
Fig. 111 Spain
Fig. 112 Spain market estimates and forecasts, 2018 - 2030
Fig. 113 Denmark
Fig. 114 Denmark market estimates and forecasts, 2018 - 2030
Fig. 115 Sweden
Fig. 116 Sweden market estimates and forecasts, 2018 - 2030
Fig. 117 Norway
Fig. 118 Norway market estimates and forecasts, 2018 - 2030
Fig. 119 Asia Pacific
Fig. 120 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 121 China
Fig. 122 China market estimates and forecasts, 2018 - 2030
Fig. 123 Japan
Fig. 124 Japan market estimates and forecasts, 2018 - 2030
Fig. 125 India
Fig. 126 India market estimates and forecasts, 2018 - 2030
Fig. 127 Thailand
Fig. 128 Thailand market estimates and forecasts, 2018 - 2030
Fig. 129 South Korea
Fig. 130 South Korea market estimates and forecasts, 2018 - 2030
Fig. 131 Australia
Fig. 132 Australia market estimates and forecasts, 2018 - 2030
Fig. 133 Latin America
Fig. 134 Latin America market estimates and forecasts, 2018 - 2030
Fig. 135 Brazil
Fig. 136 Brazil market estimates and forecasts, 2018 - 2030
Fig. 137 Mexico
Fig. 138 Mexico market estimates and forecasts, 2018 - 2030
Fig. 139 Argentina
Fig. 140 Argentina market estimates and forecasts, 2018 - 2030
Fig. 141 Middle East and Africa
Fig. 142 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 143 South Africa
Fig. 144 South Africa market estimates and forecasts, 2018 - 2030
Fig. 145 Saudi Arabia
Fig. 146 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 147 UAE
Fig. 148 UAE market estimates and forecasts, 2018 - 2030
Fig. 149 Kuwait
Fig. 150 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 151 Market share of key market players- Alopecia market

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
    • Alopecia Areata
      • Male
      • Female
    • Cicatricial Alopecia
      • Male
      • Female
    • Traction Alopecia
      • Male
      • Female
    • Alopecia Totalis
      • Male
      • Female
    • Alopecia Universalis
      • Male
      • Female
    • Androgenetic Alopecia
      • Male
      • Female
    • Others
      • Male
      • Female
  • Treatment Outlook (Revenue in USD Million, 2018 - 2030)
    • Pharmaceuticals
      • Topical
        • OTC
          • Minoxidil
          • Others
        • Prescription
          • Betamethasone Dipropionate
          • Fluocinolone Acetonide
          • Finasteride
          • Minoxidil
      • Oral
        • OTC
        • Prescription
          • Minoxidil
          • Finasteride
          • Corticosteroids
          • Others (JAK inhibitors and others)
      • PRP
    • Devices
      • Laser Cap
      • Laser Comb
      • Laser Helmet
  • Gender Outlook (Revenue in USD Million; 2018 - 2030)
    • Male
    • Female
  • Sales Channel Outlook (Revenue in USD Million; 2018 - 2030)
    • Prescriptions
    • OTC
  • End Use Outlook (Revenue in USD Million; 2018 - 2030)
    • Homecare Settings
    • Dermatology Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Alopecia Areata
          • Male
          • Female
        • Cicatricial Alopecia
          • Male
          • Female
        • Traction Alopecia
          • Male
          • Female
        • Alopecia Totalis
          • Male
          • Female
        • Alopecia Universalis
          • Male
          • Female
        • Androgenetic Alopecia
          • Male
          • Female
        • Others
          • Male
          • Female
      • North America Treatment Outlook (Revenue in USD Million, 2018 - 2030)
        • Pharmaceuticals
          • Topical
            • OTC
              • Minoxidil
              • Others
            • Prescription
              • Betamethasone Dipropionate
              • Fluocinolone Acetonide
              • Finasteride
              • Minoxidil
          • Oral
            • OTC
            • Prescription
              • Minoxidil
              • Finasteride
              • Corticosteroids
              • Others (JAK inhibitors and others)
          • PRP
        • Devices
          • Laser Cap
          • Laser Comb
          • Laser Helmet
      • North America Gender Outlook (Revenue in USD Million, 2018 - 2030)
        • Male
        • Female
      • North America Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
        • Prescriptions
        • OTC
      • North America End Use Outlook (Revenue in USD Million, 2018 - 2030)
        • Homecare Settings
        • Dermatology Clinics
      • U.S.
        • U.S. Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • U.S. Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • U.S. Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • U.S. Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • U.S. End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Canada
        • Canada Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Canada Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Canada Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Canada Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Canada End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
    • Europe
      • Europe Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Alopecia Areata
          • Male
          • Female
        • Cicatricial Alopecia
          • Male
          • Female
        • Traction Alopecia
          • Male
          • Female
        • Alopecia Totalis
          • Male
          • Female
        • Alopecia Universalis
          • Male
          • Female
        • Androgenetic Alopecia
          • Male
          • Female
        • Others
          • Male
          • Female
      • Europe Treatment Outlook (Revenue in USD Million, 2018 - 2030)
        • Pharmaceuticals
          • Topical
            • OTC
              • Minoxidil
              • Others
            • Prescription
              • Betamethasone Dipropionate
              • Fluocinolone Acetonide
              • Finasteride
              • Minoxidil
          • Oral
            • OTC
            • Prescription
              • Minoxidil
              • Finasteride
              • Corticosteroids
              • Others (JAK inhibitors and others)
          • PRP
        • Devices
          • Laser Cap
          • Laser Comb
          • Laser Helmet
      • Europe Gender Outlook (Revenue in USD Million, 2018 - 2030)
        • Male
        • Female
      • Europe Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
        • Prescriptions
        • OTC
      • Europe End Use Outlook (Revenue in USD Million, 2018 - 2030)
        • Homecare Settings
        • Dermatology Clinics
      • Germany
        • Germany Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Germany Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Germany Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Germany Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Germany End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • UK
        • UK Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • UK Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • UK Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • UK Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • UK End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • France
        • France Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • France Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • France Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • France Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • France End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Italy
        • Italy Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Italy Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Italy Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Italy Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Italy End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Spain
        • Spain Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Spain Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Spain Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Spain Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Spain End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Denmark
        • Denmark Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Denmark Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Denmark Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Denmark Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Denmark End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Sweden
        • Sweden Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Sweden Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Sweden Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Sweden Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Sweden End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Norway
        • Norway Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Norway Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Norway Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Norway Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Norway End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
    • Asia Pacific
      • Asia Pacific Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Alopecia Areata
          • Male
          • Female
        • Cicatricial Alopecia
          • Male
          • Female
        • Traction Alopecia
          • Male
          • Female
        • Alopecia Totalis
          • Male
          • Female
        • Alopecia Universalis
          • Male
          • Female
        • Androgenetic Alopecia
          • Male
          • Female
        • Others
          • Male
          • Female
      • Asia Pacific Treatment Outlook (Revenue in USD Million, 2018 - 2030)
        • Pharmaceuticals
          • Topical
            • OTC
              • Minoxidil
              • Others
            • Prescription
              • Betamethasone Dipropionate
              • Fluocinolone Acetonide
              • Finasteride
              • Minoxidil
          • Oral
            • OTC
            • Prescription
              • Minoxidil
              • Finasteride
              • Corticosteroids
              • Others (JAK inhibitors and others)
          • PRP
        • Devices
          • Laser Cap
          • Laser Comb
          • Laser Helmet
      • Asia Pacific Gender Outlook (Revenue in USD Million, 2018 - 2030)
        • Male
        • Female
      • Asia Pacific Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
        • Prescriptions
        • OTC
      • Asia Pacific End Use Outlook (Revenue in USD Million, 2018 - 2030)
        • Homecare Settings
        • Dermatology Clinics
      • China
        • China Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • China Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • China Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • China Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • China End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Japan
        • Japan Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Japan Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Japan Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Japan Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Japan End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • India
        • India Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • India Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • India Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • India Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • India End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Thailand
        • Thailand Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Thailand Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Thailand Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Thailand Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Thailand End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • South Korea
        • South Korea Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • South Korea Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • South Korea Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • South Korea Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • South Korea End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Australia
        • Australia Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Australia Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Australia Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Australia Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Australia End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
    • Latin America
      • Latin America Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Alopecia Areata
          • Male
          • Female
        • Cicatricial Alopecia
          • Male
          • Female
        • Traction Alopecia
          • Male
          • Female
        • Alopecia Totalis
          • Male
          • Female
        • Alopecia Universalis
          • Male
          • Female
        • Androgenetic Alopecia
          • Male
          • Female
        • Others
          • Male
          • Female
      • Latin America Treatment Outlook (Revenue in USD Million, 2018 - 2030)
        • Pharmaceuticals
          • Topical
            • OTC
              • Minoxidil
              • Others
            • Prescription
              • Betamethasone Dipropionate
              • Fluocinolone Acetonide
              • Finasteride
              • Minoxidil
          • Oral
            • OTC
            • Prescription
              • Minoxidil
              • Finasteride
              • Corticosteroids
              • Others (JAK inhibitors and others)
          • PRP
        • Devices
          • Laser Cap
          • Laser Comb
          • Laser Helmet
      • Latin America Gender Outlook (Revenue in USD Million, 2018 - 2030)
        • Male
        • Female
      • Latin America Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
        • Prescriptions
        • OTC
      • Latin America End Use Outlook (Revenue in USD Million, 2018 - 2030)
        • Homecare Settings
        • Dermatology Clinics
      • Brazil
        • Brazil Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Brazil Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Brazil Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Brazil Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Brazil End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Mexico
        • Mexico Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Mexico Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Mexico Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Mexico Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Mexico End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Argentina
        • Argentina Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Argentina Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Argentina Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Argentina Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Argentina End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
    • Middle East and Africa
      • Middle East and Africa Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Alopecia Areata
          • Male
          • Female
        • Cicatricial Alopecia
          • Male
          • Female
        • Traction Alopecia
          • Male
          • Female
        • Alopecia Totalis
          • Male
          • Female
        • Alopecia Universalis
          • Male
          • Female
        • Androgenetic Alopecia
          • Male
          • Female
        • Others
          • Male
          • Female
      • Middle East and Africa Treatment Outlook (Revenue in USD Million, 2018 - 2030)
        • Pharmaceuticals
          • Topical
            • OTC
              • Minoxidil
              • Others
            • Prescription
              • Betamethasone Dipropionate
              • Fluocinolone Acetonide
              • Finasteride
              • Minoxidil
          • Oral
            • OTC
            • Prescription
              • Minoxidil
              • Finasteride
              • Corticosteroids
              • Others (JAK inhibitors and others)
          • PRP
        • Devices
          • Laser Cap
          • Laser Comb
          • Laser Helmet
      • Middle East and Africa Gender Outlook (Revenue in USD Million, 2018 - 2030)
        • Male
        • Female
      • Middle East and Africa Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
        • Prescriptions
        • OTC
      • Middle Wast and Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
        • Homecare Settings
        • Dermatology Clinics
      • South Africa
        • South Africa Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • South Africa Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • South Africa Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • South Africa Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • South Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Saudi Arabia
        • Saudi Arabia Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Saudi Arabia Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Saudi Arabia Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Saudi Arabia Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Saudi Arabia End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • UAE
        • UAE Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • UAE Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • UAE Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • UAE Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • UAE End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics
      • Kuwait
        • Kuwait Disease Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Alopecia Areata
            • Male
            • Female
          • Cicatricial Alopecia
            • Male
            • Female
          • Traction Alopecia
            • Male
            • Female
          • Alopecia Totalis
            • Male
            • Female
          • Alopecia Universalis
            • Male
            • Female
          • Androgenetic Alopecia
            • Male
            • Female
          • Others
            • Male
            • Female
        • Kuwait Treatment Outlook (Revenue in USD Million, 2018 - 2030)
          • Pharmaceuticals
            • Topical
              • OTC
                • Minoxidil
                • Others
              • Prescription
                • Betamethasone Dipropionate
                • Fluocinolone Acetonide
                • Finasteride
                • Minoxidil
            • Oral
              • OTC
              • Prescription
                • Minoxidil
                • Finasteride
                • Corticosteroids
                • Others (JAK inhibitors and others)
            • PRP
          • Devices
            • Laser Cap
            • Laser Comb
            • Laser Helmet
        • Kuwait Gender Outlook (Revenue in USD Million, 2018 - 2030)
          • Male
          • Female
        • Kuwait Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
          • Prescriptions
          • OTC
        • Kuwait End Use Outlook (Revenue in USD Million, 2018 - 2030)
          • Homecare Settings
          • Dermatology Clinics

Alopecia Market Dynamics

Driver: Increasing Prevalence of Alopecia

The growing prevalence of alopecia in most countries owing to changing lifestyles, such as huge consumption of junk food, alcohol, and tobacco. Rise in stress level coupled with increasing geriatric population. These factors are responsible for the increase in alopecia cases. According to data published by the American Hair Loss Association, it was stated that over 95% of hair loss in men is caused due to androgenetic alopecia. The occurrence of hair loss in men increases proportionately with age. Based on the report published by the International Society of Hair Restoration Surgery, it was estimated that nearly 40% of men encounter some degree of hair loss by 35 years of age, 65% at 60 years, 70% at 80 years, and 80% at the age of 85.

Driver: Growing Healthcare Expenditure to Boost Market Growth

The number of healthcare expenditures is growing in several regions such as North American, Asia Pacific, Latin American, and Europe. The key factors responsible to drive healthcare expenditure include rapidly increasing geriatric population, increasing consumer disposable income, and growing emphasis on aesthetic appearance is further responsible for accelerating healthcare expenditure, thereby improving the market. In addition, rapid economic growth in developing countries along with several initiatives by organizations such as American Hair Loss Association and National Alopecia Areata Foundation spreading awareness of alopecia treatment which drive the market growth over the forecast period.

Restraint: Increasing Adoption of Alternatives to Hamper Market Growth

Increased adoption of substitutes such as - Ayurvedic, Chinese, and herbal medications is anticipated to hamper market growth in the coming years. Furthermore, growing advanced technology in the healthcare industry has posed a threat to growth of the alopecia market.

What Does This Report Include?

This section will provide insights into the contents included in this alopecia market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Alopecia market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Alopecia market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

Grand View Research employs a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:

Preliminary data mining

Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.

Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.

Statistical model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.

Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:

    • Market drivers and restraints, along with their current and expected impact
    • Raw material scenario and supply v/s price trends
    • Regulatory scenario and expected developments
    • Current capacity and expected capacity additions up to 2030

We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.

Primary validation

This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts, and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation but also provide critical insights into the market, current business scenario, and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:

    • Market-leading companies
    • Raw material suppliers
    • Product distributors
    • Buyers

The key objectives of primary research are as follows:

    • To validate our data in terms of accuracy and acceptability
    • To gain an insight in to the current market and future expectations

Data Collection Matrix

Perspective

Primary research

Secondary research

Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data

Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Industry Analysis Matrix

Qualitative analysis

Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2030
  • Market revenue estimates and forecasts up to 2030, by technology
  • Market revenue estimates and forecasts up to 2030, by application
  • Market revenue estimates and forecasts up to 2030, by type
  • Market revenue estimates and forecasts up to 2030, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

 

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.